Drs. John Lasala, Bill O’Neill, Jeff Moses, and Bill Lombardi explain the benefit of Impella support during Protected PCI for revascularization.
Impella 2.5 and Impella CP are now approved by the FDA as safe and effective for use during high-risk PCI procedures. Learn more about the data and the clinical guidelines that support the approval. Additionally, learn how to identify patients who can benefit from Protected PCI and revascularization. Tune into this valuable conversation! Chapters include:
Continue readingThe Benefit of Impella® Support During Protected PCI for Revascularization
- Maintaining Hemodynamic stability during high-risk PCI
- Complete Revascularization is the Therapeutic Goal
- Clinical Outcomes with PCI
With TCT 2015 having wrapped up last week, it's a good time to take a look back at the top event topics discussed on Twitter. Last week, the Protected PCI blogging team attended the event, participated in social media, and blogged on our top event takeaways
. So this week, we'll uncover the top takeaways from the nearly 7000 tweets that used the hashtag #TCT2015 during the event. Continue readingHow Cardiologists Used Twitter During #TCT2015 (Plus an Interview with C. Michael Gibson)